The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Medtronic (NYSE:MDT) is shutting down heart valve maker Ventor Technologies, which it acquired in 2009, and moving its R&D efforts to other site, according to an Israeli business journal.
Netanya, Israel-based Ventor is developing an aortic replacement valve called the Engager. Medtronic bought the company for $325 million 3 years ago.
European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
Advanced Cell Technology (OTC:ACTC) appointed MIT professor and bioengineering legend Bob Langer to its board of directors, tapping him to lead its science advisory committee.
Langer has authored more than 1,100 journal articles, has more than 800 issued and pending patents and won the 2011 Warren Alpert Foundation Prize for bioengineering pioneers thanks to his work in drug delivery and tissue engineering.
Medidata Solutions Appoints Bryan Spielman Executive Vice President of Strategy and Corporate Development
Spielman to Work with Business Groups to Drive Partnerships and Growth Initiatives
NEW YORK–(BUSINESS WIRE)–Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Bryan Spielman has been named executive vice president of strategy and corporate development, reporting to CEO Tarek Sherif and President Glen de Vries. Bryan will oversee strategic planning and corporate development activities with a focus on strengthening Medidata through strategic partnerships and corporate initiatives that will continue to drive competitive advantage for its clinical research customers.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
